Realtime | Geld | Brief | Zeit |
---|---|---|---|
12,850 | 13,050 | 14:24 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Pihlajalinna Oyj: Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors of Pihlajalinna Plc | 36 | GlobeNewswire (Europe) | Pihlajalinna Plc Stock Exchange Release 24 April 2025 at 2:00 p.m.
Resolutions of the Annual General Meeting and the constitutive meeting of the Board of Directors... ► Artikel lesen | |
16.04. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Intermin Report for January 1-March 31, 2025, on Wednesday, 30 April 2025 | 1 | Cision News | ||
01.04. | PIHLAJALINNA OYJ: Pihlajalinna has published the 2024 Annual Report | 1 | Cision News | ||
25.03. | PIHLAJALINNA OYJ: Invitation to Pihlajalinna's Capital Markets Day on 9 May 2025 | 1 | Cision News | ||
19.03. | PIHLAJALINNA OYJ: Pihlajalinna Plc: Notice to Annual General Meeting | 1 | Cision News | ||
PIHLAJALINNA Aktie jetzt für 0€ handeln | |||||
14.03. | PIHLAJALINNA OYJ: Pihlajalinna's disposal of own shares based on the share-based incentive programme | 2 | Cision News | ||
12.02. | Pihlajalinna Oyj: Pihlajalinna Financial Statements Release 1 January-31 December 2024: Strong organic growth, operating cash flow and profitability development in 2024 | 63 | GlobeNewswire (Europe) | Pihlajalinna Plc Financial Statements Release 12 February 2025 at 8:00 a.m.
Pihlajalinna Financial Statements Release 1 January-31 December 2024
Strong organic growth, operating cash flow... ► Artikel lesen | |
28.01. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Financial Statements Release 2024 on Wednesday, 12 February 2025 | 1 | Cision News | ||
17.01. | PIHLAJALINNA OYJ: Proposals of Pihlajalinna Plc's Shareholders' Nomination Board to the 2025 Annual General Meeting | 1 | Cision News | ||
13.12.24 | PIHLAJALINNA OYJ: Pihlajalinna establishes a new long-term share-based incentive plan for key employees | 1 | Cision News | ||
11.11.24 | PIHLAJALINNA OYJ: Pihlajalinna Plc: Managers' transactions | 2 | Cision News | ||
07.11.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-30 September 2024: Solid development in organic growth and profitability | 74 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 7 November 2024 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-30 September 2024
Solid development in organic... ► Artikel lesen | |
30.10.24 | Pihlajalinna Oyj: Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the third quarter of 2024 | 102 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 October 2024 at 8:00 a.m.
Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance... ► Artikel lesen | |
28.10.24 | PIHLAJALINNA OYJ: Insider information: The Wellbeing Services County of Pirkanmaa terminates the complete outsourcing agreement of Kolmostien Terveys | 2 | Cision News | ||
09.08.24 | Pihlajalinna Oyj: Pihlajalinna Half Year Financial Report 1 January-30 June 2024: Profitability and customer satisfaction continued to improve | 131 | GlobeNewswire (Europe) | Pihlajalinna Plc Half Year Financial Report 9 August 2024 at 8:00 a.m.
Pihlajalinna Half Year Financial Report 1 January-30 June 2024
Profitability and customer... ► Artikel lesen | |
17.07.24 | Pihlajalinna Oyj: Insider information, profit warning: Pihlajalinna raises its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the second quarter of 2024 | 113 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 17 July 2024 at 8:00 a.m.
Insider information, profit warning: Pihlajalinna raises its profitability guidance for 2024 and provides preliminary... ► Artikel lesen | |
03.05.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong | 127 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 3 May 2024 at 8:00
Pihlajalinna Interim Report 1 January-31 March 2024
Profitability continued to improve, operating... ► Artikel lesen | |
03.05.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong | 81 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 3 May 2024 at 8:00
Pihlajalinna Interim Report 1 January-31 March 2024
Profitability continued to improve, operating... ► Artikel lesen | |
30.04.24 | Pihlajalinna Oyj: Insider information, profit warning: Pihlajalinna decreases its revenue outlook as the cost liability of demanding care transfers to the well-being services county of South Ostrobothnia | 83 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 April 2024 at 2:30 p.m.
Insider information, profit warning: Pihlajalinna decreases its revenue outlook as the cost liability of demanding care transfers... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BICO GROUP | 3,642 | +2,19 % | BICO Group Aktie: Strategische Neuausrichtung | BICO Group verkauft MatTek und Visikol für 80 Millionen US-Dollar an Sartorius und fokussiert sich stärker auf Labortechnik. Zudem stehen Personalwechsel und Quartalszahlen an. Verkauf von Tochtergesellschaften... ► Artikel lesen | |
PING AN HEALTHCARE | 0,804 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
EMEIS | 10,250 | -3,34 % | emeis: 2024 Full-Year Results | Trajectory for recovery confirmed
Improvement in CSR fundamentals
2024 guidance beaten, with an operational recovery in the second half
2025 EBITDAR expected to rise between +15% and +18%... ► Artikel lesen | |
CYTOSORBENTS | 1,060 | +4,54 % | CytoSorbents Gains $1.7M Via NJEDA Tax Credit Sale To Fund Strategic Growth | ||
CLARIANE | 3,574 | -5,80 % | Clariane I 2025 first-quarter revenue | Press release Revenue for the three months to 31 March 2025 rose by 4.8% on an organic basis, which equates to a 5.5% increase on a comparable number of days.All businesses and regions contributed... ► Artikel lesen | |
ARJO | 2,970 | -1,07 % | Arjo AB Aktie: Umsatzplus im überblickbaren Bereich! | Der schwedische Medizintechnikkonzern meldet Umsatzsteigerung trotz volatiler Börsenperformance und erhält wichtige FDA-Zulassung für neue Diagnostiktechnologie. Arjo AB hat für Dienstag, den 29. April... ► Artikel lesen | |
M3 INC | 11,300 | +1,80 % | MEDIROM Healthcare Technologies Inc.: M3 Group Joins MEDIROM Mother Labs' Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation | ||
INTERPACE BIOSCIENCES | 0,790 | 0,00 % | Interpace Biosciences, Inc.: Effective May 2, 2025, Interpace Diagnostics Will No Longer Accept Specimens for PancraGEN, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk | Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace"... ► Artikel lesen | |
NYXOAH | 5,290 | 0,00 % | Stifel cuts Nyxoah stock price target to $14, maintains Buy rating | ||
DYNAVOX GROUP | 6,555 | +25,57 % | Dynavox Group AB: Dynavox Group Interim Report first quarter 2025 | Dynavox Group AB (publ) today announced its results for the first quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
During the first quarter, typically our slowest in terms of volume... ► Artikel lesen | |
VIVANI MEDICAL | 0,900 | -1,10 % | Vivani Medical, Inc.: Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity | ALAMEDA, Calif. and SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature... ► Artikel lesen | |
CHINA MEDICAL SYSTEM | 0,970 | -2,51 % | CMS (00867): FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | ||
NANOSONICS | 2,540 | +0,79 % | Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today | ||
NIAGEN BIOSCIENCE | 6,000 | -7,69 % | ChromaDex Aktie: Stabile Wachstumspfade | Das ehemals als ChromaDex bekannte Unternehmen verzeichnet beeindruckendes Umsatzwachstum, erweitert sein Portfolio und erhält wichtige FDA-Anerkennungen für Gesundheitsprodukte. Niagen Bioscience,... ► Artikel lesen | |
MICROPORT SCIENTIFIC | 0,800 | +0,63 % | Shanghai MicroPort Medbot (Group) Co., Ltd.: MICROPORT MEDBOT'S TOUMAI ENDOSCOPIC SURGICAL ROBOT SYSTEM COMPLETES MULTIPLE LANDMARK ROBOTIC TELESURGERY CASES IN SUB-SAHARA AFRICA IN THE REPUBLIC OF ANGOLA | SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- October 24, 2024, MicroPort® MedBotTM (HKSE:2252) announced that the company successfully completed 6 robot-assisted laparoscopic radical prostatectomy... ► Artikel lesen |